肺癌实验室诊断专家共识

2018-09-19 中国医师协会检验医师分会 山东大学学报(医学版).2018.56(10):1-10.

目前国内尚缺乏系统的关于以上肺癌相关标志物实验室质量管理及应用方面的指导性文件,因此为进一步规范和提高肺癌相关TM以及核酸分子标志物实验室检查质量。为肺癌的诊疗工作提供更可靠的数据和应用支持,“中国医师协会检验医师分会肺癌专家委员会”起草了«肺癌实验室诊断专家共识»。本共识涉及“血清学标志物”和“核酸分子标志物”两部分ꎮ重点梳理肺癌相关TM 与核酸分子标志物实验室检查及临床应用的管理要点,为实验室

中文标题:

肺癌实验室诊断专家共识

发布日期:

2018-09-19

简要介绍:

目前国内尚缺乏系统的关于以上肺癌相关标志物实验室质量管理及应用方面的指导性文件,因此为进一步规范和提高肺癌相关TM以及核酸分子标志物实验室检查质量。为肺癌的诊疗工作提供更可靠的数据和应用支持,“中国医师协会检验医师分会肺癌专家委员会”起草了«肺癌实验室诊断专家共识»。本共识涉及“血清学标志物”和“核酸分子标志物”两部分ꎮ重点梳理肺癌相关TM 与核酸分子标志物实验室检查及临床应用的管理要点,为实验室人员、临床医生等提供有价值的参考依据。更好地发挥其临床应用价值。 

拓展指南:肺癌相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=肺癌实验室诊断专家共识)] GetToolGuiderByIdResponse(projectId=1, id=499db1c0016a2894, title=肺癌实验室诊断专家共识, enTitle=, guiderFrom=山东大学学报(医学版).2018.56(10):1-10., authorId=null, author=, summary=目前国内尚缺乏系统的关于以上肺癌相关标志物实验室质量管理及应用方面的指导性文件,因此为进一步规范和提高肺癌相关TM以及核酸分子标志物实验室检查质量。为肺癌的诊疗工作提供更可靠的数据和应用支持,“中国医师协会检验医师分会肺癌专家委员会”起草了«肺癌实验室诊断专家共识»。本共识涉及“血清学标志物”和“核酸分子标志物”两部分ꎮ重点梳理肺癌相关TM 与核酸分子标志物实验室检查及临床应用的管理要点,为实验室, cover=, journalId=null, articlesId=null, associationId=1260, associationName=中国医师协会检验医师分会, associationIntro=, copyright=0, guiderPublishedTime=Wed Sep 19 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>目前国内尚缺乏系统的关于以上肺癌相关标志物实验室质量管理及应用方面的指导性文件,因此为进一步规范和提高肺癌相关TM以及核酸分子标志物实验室检查质量。为肺癌的诊疗工作提供更可靠的数据和应用支持,“中国医师协会检验医师分会肺癌专家委员会”起草了«肺癌实验室诊断专家共识»。本共识涉及“血清学标志物”和“核酸分子标志物”两部分ꎮ重点梳理肺癌相关TM 与核酸分子标志物实验室检查及临床应用的管理要点,为实验室人员、临床医生等提供有价值的参考依据。更好地发挥其临床应用价值。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>肺癌</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=d58691c0016336b4" title="NCCN临床实践指南:肺癌筛查(2019.V2)" target=_blank>NCCN临床实践指南:肺癌筛查(2019.V2)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=8ef751c0016308ff" title="NCCN临床实践指南:非小细胞肺癌(2018.V6)" target=_blank>NCCN临床实践指南:非小细胞肺癌(2018.V6)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=6508d1c0016181b8" title="2018 CCO指南:小细胞肺癌的初期管理以及胸部放疗和一线化疗的作用" target=_blank>2018 CCO指南:小细胞肺癌的初期管理以及胸部放疗和一线化疗的作用</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=c7b0d1c00161013a" title="NCCN临床实践指南:非小细胞肺癌(2018.V5)" target=_blank>NCCN临床实践指南:非小细胞肺癌(2018.V5)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=03b721c00160a4bc" title="NCCN临床实践指南:肺癌筛查(2019.V1)" target=_blank>NCCN临床实践指南:肺癌筛查(2019.V1)</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E8%82%BA%E7%99%8C" target=_blank>有关肺癌更多指南</a></ul>, tagList=[TagDto(tagId=428, tagName=肺癌), TagDto(tagId=58718, tagName=实验室诊断)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=69, categoryName=检验, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6141, appHits=382, showAppHits=0, pcHits=4479, showPcHits=1697, likes=103, shares=12, comments=4, approvalStatus=1, publishedTime=Sat Sep 22 15:19:50 CST 2018, publishedTimeString=2018-09-19, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Sep 22 15:19:50 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 00:27:13 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=肺癌实验室诊断专家共识)])
肺癌实验室诊断专家共识
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1208588, encodeId=6dad120858802, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00ec8098175, createdName=ms3000000771933475, createdTime=Mon Apr 04 18:52:24 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=371219, encodeId=6a733e1219b1, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d975160580, createdName=146b698bm11暂无昵称, createdTime=Tue Aug 13 23:13:07 CST 2019, time=2019-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346796, encodeId=0196346e96b8, content=转发给研究所的同志, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8e425737, createdName=tw007007, createdTime=Wed Sep 26 16:47:07 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346178, encodeId=ed943461e8d3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sat Sep 22 17:19:20 CST 2018, time=2018-09-22, status=1, ipAttribution=)]
    2022-04-04 ms3000000771933475

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1208588, encodeId=6dad120858802, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00ec8098175, createdName=ms3000000771933475, createdTime=Mon Apr 04 18:52:24 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=371219, encodeId=6a733e1219b1, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d975160580, createdName=146b698bm11暂无昵称, createdTime=Tue Aug 13 23:13:07 CST 2019, time=2019-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346796, encodeId=0196346e96b8, content=转发给研究所的同志, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8e425737, createdName=tw007007, createdTime=Wed Sep 26 16:47:07 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346178, encodeId=ed943461e8d3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sat Sep 22 17:19:20 CST 2018, time=2018-09-22, status=1, ipAttribution=)]
    2019-08-13 146b698bm11暂无昵称

    谢谢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1208588, encodeId=6dad120858802, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00ec8098175, createdName=ms3000000771933475, createdTime=Mon Apr 04 18:52:24 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=371219, encodeId=6a733e1219b1, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d975160580, createdName=146b698bm11暂无昵称, createdTime=Tue Aug 13 23:13:07 CST 2019, time=2019-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346796, encodeId=0196346e96b8, content=转发给研究所的同志, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8e425737, createdName=tw007007, createdTime=Wed Sep 26 16:47:07 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346178, encodeId=ed943461e8d3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sat Sep 22 17:19:20 CST 2018, time=2018-09-22, status=1, ipAttribution=)]
    2018-09-26 tw007007

    转发给研究所的同志

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1208588, encodeId=6dad120858802, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00ec8098175, createdName=ms3000000771933475, createdTime=Mon Apr 04 18:52:24 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=371219, encodeId=6a733e1219b1, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d975160580, createdName=146b698bm11暂无昵称, createdTime=Tue Aug 13 23:13:07 CST 2019, time=2019-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346796, encodeId=0196346e96b8, content=转发给研究所的同志, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8e425737, createdName=tw007007, createdTime=Wed Sep 26 16:47:07 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346178, encodeId=ed943461e8d3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sat Sep 22 17:19:20 CST 2018, time=2018-09-22, status=1, ipAttribution=)]
    2018-09-22 医者仁心5538

    学习了

    0